Logotype for Proto Labs Inc

Proto Labs (PRLB) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Proto Labs Inc

Q3 2024 earnings summary

17 Jan, 2026

Executive summary

  • Q3 2024 revenue was $125.6M, down 3.9%–4.3% year-over-year, with flat sequential performance and strong execution despite manufacturing sector challenges.

  • Non-GAAP EPS was $0.47, up $0.09 sequentially but down $0.04 year-over-year; GAAP net income was $7.2M ($0.29/share).

  • Gross margin improved to 45.6% (GAAP) and 46.2% (non-GAAP), driven by cost reductions and automation.

  • Protolabs Network revenue grew 11%–11.6% year-over-year to $25.3M; customer contacts using combined services increased 35%.

  • Board approved closure of a German facility and discontinuation of certain 3D printing services, with $4.5M–$6.0M in restructuring charges expected.

Financial highlights

  • Q3 2024 revenue: $125.6M (down 3.9%–4.3% year-over-year); gross profit: $57.2M; gross margin: 45.6% (GAAP), 46.2% (non-GAAP).

  • Non-GAAP operating margin was 10.9%, up 200 bps sequentially; GAAP operating margin was 6.8%.

  • Operating cash flow reached $24.8M, the highest since 2020; cash and investments totaled $117.6M, with no debt.

  • Adjusted EBITDA was $21.9M (17.4% margin), down from $23.9M (18.3%) a year ago.

  • Repurchased $19.0M of common shares in Q3; $46.0M repurchased in the first nine months of 2024.

Outlook and guidance

  • Q4 2024 revenue expected between $115M and $123M; non-GAAP EPS guidance is $0.28–$0.36.

  • Q4 GAAP diluted EPS expected between $0.10 and $0.18; includes $4.0M–$4.4M in restructuring charges.

  • Foreign currency expected to have a $1M favorable impact on Q4 revenue.

  • Q4 non-GAAP effective tax rate projected at 20% ± 50 bps; diluted shares outstanding about 25M.

  • Existing cash and cash flow from operations deemed sufficient for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more